Segmented assays with type-specific antigens eliminate cross-reactivity, resolving false positives in HSV-2 diagnostics.
Pectin and transglutaminase form edible scaffolds, resolving inedibility trade-offs.
Stable CD19 expression on HeLa cells resolves the lack of reliable models for leukemia research and enables effective CAR-T therapy testing.
Extruded microcarrier beads feature a porous three-dimensional core enclosed by an outer protective layer to support anchorage-dependent cell growth.
Monoclonal antibodies detect the AAD-12 protein with high specificity, resolving field usability challenges in transgenic monitoring.
A microfluidic channel with ferromagnetic patterns captures cancer cells using magnetic force and flow velocity control.
A plastic support positions excised organs to enable precise foreign substance injection while reducing puncture damage.
Anti-GnRH-R antibody staining detects myelin distribution, replacing complex multi-step protocols to simplify detection while maintaining precision.
Transgenic pigs expressing human APOBEC3F and APOBEC3G enzymes mutate PERV genomes, resolving the contradiction between islet availability and disease safety.
Normal cells secrete multiple lysosomal enzymes into culture medium, eliminating complex recombinant purification steps.
Monoclonal antibodies detect the AAD-1 enzyme in plant tissues using sandwich ELISA and lateral flow strip methods.
High-affinity human monoclonal antibodies target PTK7-expressing tumor cells, inhibiting cell growth and slowing progression in cancers such as colon and lung.
Engineered humanized RP215 antibodies maintain murine binding affinity while minimizing immunogenicity in humans.
GDF15 modulators address fibrous scar tissue formation beneath the retina by targeting pathological pathways distinct from VEGF inhibition.
Isolated promoter polynucleotides eliminate baculovirus stock instability to deliver reproducible protein expression levels without specialized facilities.
Combining RNAi, reporter, and target sequences in one construct bypasses inefficient algorithm predictions to identify potent molecules.
Repressible promoter cell lines quantify test compound effects on epigenetic marks to prevent tumor suppressor gene re-silencing.
Sealing means with biomarker prevents cross-infection and dehydration during invasive egg testing.
Alternating tangential flow filtration concentrates cells to high densities while maintaining viability, avoiding mechanical damage from centrifugation.
Segmenting the beta3 subunit spares alphaIIb-mediated hemostasis, reducing bleeding risks during antithrombotic therapy.
A hapten compound conjugated to a carrier protein induces specific monoclonal antibodies against mercaptoundecahydrododecaborate.
Biological synthesis replaces costly chemical routes by eliminating harsh reagents and extensive purification steps.
A decalcified bone matrix framework filled with degradable bio-gel creates a composite scaffold structure.
MicroRNA expression profiling assesses stem cell quality and safety by detecting phenotypic drift and tumorigenicity risks.
A cell culture carrier uses a support-held organic thin film to enable easy detachment of tissue sheets without dimensional contraction.
A monoclonal antibody binds diacetylspermine with high affinity to enable precise detection in biological samples.
A glucose dehydrogenase mutant enables direct electron transfer to electrodes without mediators.
Isolating the Chinese hamster growth hormone polyadenylation signal resolves low protein expression levels by optimizing mRNA processing for higher titers.
Stem cells from human nasal inferior turbinate tissue with increased HAS2, CXCL1, or KRTAP1-5 expression suppress joint destruction while reducing side effects.
Engineered CHO cells express 2,6-linked sialic acids to increase influenza virus binding sites.
Specific dipeptides supplement serum-free culture media to boost recombinant protein titer and cell viability.
Novel anti-VEGF antibodies utilize optimized complementarity determining regions to achieve high binding affinity and inhibit angiogenesis.
An antagonistic antibody binds specifically to Toll-like Receptor 2, blocking activation and reducing IL-8 production in rheumatoid arthritis.
Baculoviral expression yields recombinant spider silk proteins that self-assemble into high-tensile fibers, bypassing the need to culture territorial spiders.
A cell recovery method uses a chelator and fine pore filter to isolate tissues from suspension culture media.
Targeted viral vectors enable localized anti-CTLA-4 secretion at tumors, reducing systemic toxicity while enhancing immune responses.
Anti-P-selectin antibodies bind P-selectin to block PSGL-1 adhesion, reducing vasoocclusive events in sickle cell disease.
Stable genomic integration of engineered tRNA and synthetase sequences enables reproducible, high-titer unnatural amino acid incorporation in mammalian cells.
An antibody binds specifically to phosphorylated TDP-43 protein aggregates for targeted detection.
A microfluidic culture system uses diffusion-constrained environments to support heterogeneous cell proliferation and signaling.
Applying an edible plant-derived adhesion improver to porous scaffolding materials resolves poor cell adhesion in three-dimensional cultured meat production.
Accurate Api m3 cloning resolves sequence conflicts to provide reliable recombinant allergens for desensitization therapy.
Acryl group modification enables crosslinking of tissue-derived extracellular matrix into hydrogels that replicate fibrotic tissue structures.
Knob-into-hole CH3 substitutions resolve purity contradictions by preventing homodimer formation while maintaining glycosylation in mammalian cell lines.
Hollow fiber membrane filtration concentrates cell suspensions by controlling initial filtrate flow rate relative to linear velocity.
A cell transplanting kit uses a gel protection portion to cover the cell group during aspiration into a needle-shaped portion.
Vaccinating with alpha-synuclein fragments triggers an immune response that clears Lewy bodies, reducing neuronal degeneration in Parkinson's disease models.